Canada Pension Plan Investment Board’s Alexion Pharmaceuticals ALXN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,500,325	Closed	-$276M	–	1504
2021 Q2	$276M	Buy	1,500,325 +880,985	+142%	+$151M	0.33%	85
2021 Q1	$94.7M	Buy	619,340 +403,009	+186%	+$62.3M	0.12%	180
2020 Q4	$33.8M	Sell	216,331 -24,066	-10%	-$3.09M	0.05%	278
2020 Q3	$27.5M	Buy	240,397 +10,735	+5%	+$1.16M	0.05%	234
2020 Q2	$25.8M	Sell	229,662 -489,013	-68%	-$51.9M	0.06%	217
2020 Q1	$64.5M	Buy	718,675 +325,509	+83%	+$31.9M	0.17%	104
2019 Q4	$42.5M	Sell	393,166 -77,196	-16%	-$8.26M	0.08%	184
2019 Q3	$46.1M	Sell	470,362 -102,337	-18%	-$11.5M	0.09%	178
2019 Q2	$75M	Buy	572,699 +128,418	+29%	+$16.6M	0.15%	123
2019 Q1	$60.1M	Buy	444,281 +234,928	+112%	+$29.2M	0.12%	143
2018 Q4	$20.4M	Sell	209,353 -111,284	-35%	-$13.2M	0.05%	334
2018 Q3	$44.6M	Sell	320,637 -75,513	-19%	-$9.47M	0.08%	194
2018 Q2	$49.2M	Buy	396,150 +212,971	+116%	+$24.9M	0.09%	178
2018 Q1	$20.4M	Sell	183,179 -394,517	-68%	-$47.2M	0.03%	398
2017 Q4	$69.1M	Buy	577,696 +185,000	+47%	+$22.5M	0.13%	139
2017 Q3	$55.1M	Buy	392,696 +40,900	+12%	+$5.56M	0.11%	172
2017 Q2	$42.8M	Buy	351,796 +92,866	+36%	+$10.8M	0.1%	176
2017 Q1	$31.4M	Buy	258,930 +193,514	+296%	+$24.9M	0.08%	202
2016 Q4	$8M	Buy	65,416 +28,779	+79%	+$3.52M	0.03%	412
2016 Q3	$4.49M	Buy	36,637 +35,987	+5,536%	+$4.63M	0.02%	549
2016 Q2	$76K	Sell	650 -24,200	-97%	-$3.43M	﹤0.01%	1003
2016 Q1	$3.46M	Sell	24,850 -29,561	-54%	-$4.34M	0.01%	631
2015 Q4	$10.4M	Buy	54,411 +1,369	+3%	+$239K	0.05%	351
2015 Q3	$8.29M	Buy	53,042 +46,892	+762%	+$8.55M	0.03%	434
2015 Q2	$1.11M	Sell	6,150 -9,072	-60%	-$1.57M	﹤0.01%	810
2015 Q1	$2.64M	Sell	15,222 -19,720	-56%	-$3.57M	0.01%	709
2014 Q4	$6.46M	Buy	34,942 +22,869	+189%	+$4.24M	0.02%	570
2014 Q3	$2M	Sell	12,073 -1,750	-13%	-$287K	0.01%	736
2014 Q2	$2.16M	Sell	13,823 -10,981	-44%	-$1.73M	0.01%	746
2014 Q1	$3.77M	Buy	24,804 +10,423	+72%	+$1.66M	0.02%	638
2013 Q4	$1.91M	Buy	14,381 +2,101	+17%	+$252K	0.01%	743
2013 Q3	$1.43M	Buy	12,280 +180	+1%	+$19.7K	0.01%	715
2013 Q2	$1.12M	Buy	+12,100	New	+$1.17M	0.01%	638

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Canada Pension Plan Investment Board's ALXN Position: Q3 2021 in Review

Canada Pension Plan Investment Board sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,500,325 shares — an estimated $276M sold.

Canada Pension Plan Investment Board first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $276M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Canada Pension Plan Investment Board reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Canada Pension Plan Investment Board sold 1,500,325 Alexion Pharmaceuticals shares in Q3 2021, an estimated $276M.
Canada Pension Plan Investment Board first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
Canada Pension Plan Investment Board's Alexion Pharmaceuticals position peaked at $276M in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2021, filed 15 Nov 2021.